Feng Gu

Feng Gu

Auto-generated profile, based on publicly available information

Feng Gu

Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5122

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
FGFeng Gu
Feng Gu
IPIsabel Parada
Isabel Parada
TYTao Yang
Tao Yang
FLFrank M. Longo
Frank M. Longo
DPDavid A. Prince
David A. Prince
Significance: Dravet syndrome (DS) is a severe childhood epileptic encephalopathy characterized by intractable seizures and comorbidities, including a high rate of premature mortality. DS is mainly caused by loss-of-function mutations of the Scn1a gene encoding sodium channel Na v 1.1 that is predominantly expressed in inhibitory parvalbumin-containing (PV) interneurons. Decreased Na v 1.1 impairs PV cell function, causing DS phenotypes. Effective pharmacological therapy targeting defective PV interneurons is currently not available. This study demonstrated that early treatment with a partial TrkB receptor agonist, LM22A-4, increased Na v 1.1 expression, improved PV interneuron function, and reduced seizure occurrence and mortality rate in DS mice, suggesting a potential therapy for DS.